IFM Investors Pty Ltd boosted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 9.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 249,570 shares of the pharmacy operator's stock after acquiring an additional 21,480 shares during the period. IFM Investors Pty Ltd's holdings in CVS Health were worth $15,693,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also added to or reduced their stakes in CVS. OneDigital Investment Advisors LLC increased its position in CVS Health by 0.4% during the 1st quarter. OneDigital Investment Advisors LLC now owns 400,955 shares of the pharmacy operator's stock worth $27,165,000 after buying an additional 1,463 shares during the period. 44 Wealth Management LLC increased its position in CVS Health by 7.9% during the 1st quarter. 44 Wealth Management LLC now owns 37,059 shares of the pharmacy operator's stock worth $2,511,000 after buying an additional 2,716 shares during the period. Silver Oak Securities Incorporated bought a new position in CVS Health during the 1st quarter worth $292,000. Calamos Advisors LLC increased its position in CVS Health by 1.1% during the 1st quarter. Calamos Advisors LLC now owns 220,518 shares of the pharmacy operator's stock worth $14,940,000 after buying an additional 2,451 shares during the period. Finally, Aviance Capital Partners LLC bought a new position in CVS Health during the 1st quarter worth $305,000. Institutional investors own 80.66% of the company's stock.
Insider Activity
In related news, Director Guy P. Sansone acquired 1,570 shares of the stock in a transaction dated Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by company insiders.
CVS Health Trading Up 1.2%
CVS Health stock traded up $0.78 during trading hours on Friday, hitting $67.38. The stock had a trading volume of 3,770,987 shares, compared to its average volume of 10,851,185. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The stock has a market cap of $85.23 billion, a price-to-earnings ratio of 16.08, a P/E/G ratio of 0.97 and a beta of 0.57. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The business's 50 day simple moving average is $65.11 and its 200-day simple moving average is $61.58.
CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period last year, the company earned $1.31 earnings per share. The business's quarterly revenue was up 7.0% on a year-over-year basis. On average, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the company. Royal Bank Of Canada increased their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Piper Sandler increased their target price on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a report on Friday, March 21st. Barclays set a $79.00 target price on CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Mizuho increased their target price on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 price objective (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $75.06.
Check Out Our Latest Analysis on CVS Health
CVS Health Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
